BlackRock »

Bioxcel Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $564k 441k 1.28
2024-03-31 $3.7M 1.3M 2.82
2023-09-30 $3.3M 1.3M 2.53
2023-06-30 $9.3M 1.4M 6.66
2023-03-31 $26M 1.4M 18.66
2022-12-31 $31M 1.5M 21.48
2022-06-30 $19M 1.4M 13.22
2021-06-30 $33M 1.1M 29.04
2021-03-31 $46M 1.1M 43.17
2020-12-31 $42M 900k 46.20
2020-09-30 $35M 810k 43.37
2020-03-31 $11M 499k 22.40
2019-12-31 $5.8M 401k 14.59
2019-09-30 $2.2M 309k 7.06
2019-06-30 $3.3M 299k 10.88
2019-03-31 $143k 14k 9.98
2018-12-31 $61k 15k 3.99
2018-09-30 $124k 16k 7.98
2018-06-30 $134k 15k 8.98